Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Device Makers See Easier Approval Process Coming To Japan

This article was originally published in PharmAsia News

Executive Summary

Makers of medical devices anticipate quicker Japanese action on future approvals in the wake of recent moves by regulators. New reimbursement measures have been approved and recent trade talks indicate future slight changes in a product will not suffer the full approval process. Philip Agress, vice president of AdvaMed, said Japan now has the slowest approval process in the industrialized world and foreign companies have had to jump through more hoops than domestic makers. The Japanese market for medical devices, at $20 billion, is second only to that of the United States. (Click here for more

Latest Headlines
See All
UsernamePublicRestriction

Register

SC069463

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel